JEFFREY L EDWARDS
CIK 1190642 · EVP, Fin & Bus. Dev., CFO · last filed 2026-06-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$570.1K
Companies
7
Total Filings
60
Lifetime Open-Market Net
-$59.20M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KYNB | Director | — | $6.89 | — | $0 | 1 | 2026-06-17 |
| BIO.B | Director | 715 | $309.37 | $221.2K | $0 | 3 | 2026-04-23 |
| KYNTRA BIO, INC. (FGEN) Delisted | Director | 1,675 | $9.75 | $16.3K | -$135.6K | 11 | 2025-06-06 |
| LFCR | Director | 79,667 | $4.38 | $348.9K | $0 | 5 | 2024-07-10 |
| Clearside Biomedical, Inc. (CLSD) Delisted | Director | — | $0.35 | — | $0 | 7 | 2024-06-21 |
| LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Director | 12,457 | $8.76 | $109.1K | $0 | 5 | 2022-06-07 |
| ALLERGAN INC (AGN) Delisted | EVP, Fin & Bus. Dev., CFO | 58,153 | — | — | -$59.07M | 27 | 2014-02-25 |
Recent Filings · Page 5 of 6
60 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-02-20 | ALLERGAN INC (AGN) Delisted | Tax (F) | −201 | -$21.7K | EDGAR |
| 2012-11-21 | ALLERGAN INC (AGN) Delisted | Mixed | +1,000 | -$2.01M | EDGAR |
| 2012-05-07 | ALLERGAN INC (AGN) Delisted | Mixed | +538 | -$5.40M | EDGAR |
| 2012-02-24 | ALLERGAN INC (AGN) Delisted | Tax (F) | −106 | -$9.3K | EDGAR |
| 2012-02-22 | ALLERGAN INC (AGN) Delisted | Grant (A) | +535 | $0 | EDGAR |
| 2011-05-11 | ALLERGAN INC (AGN) Delisted | Mixed | +2,642 | -$1.14M | EDGAR |
| 2011-02-22 | ALLERGAN INC (AGN) Delisted | Grant (A) | +547 | $0 | EDGAR |
| 2010-11-10 | ALLERGAN INC (AGN) Delisted | Mixed | +3,189 | -$1.44M | EDGAR |
| 2010-07-16 | ALLERGAN INC (AGN) Delisted | Mixed | — | -$1.41M | EDGAR |
| 2010-02-24 | ALLERGAN INC (AGN) Delisted | Grant (A) | +287 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.